NorthView Acquisition Corp，一家特殊目的收购公司（SPAC），已发布其第三季度的 10-Q 报告，详细说明了重要的财务和运营发展。该公司正在与位于加利福尼亚的生物技术公司 Profusa, Inc.合并，并提供了报告期间的财务表现和战略业务活动的见解。
财务亮点
<ul>
<li>运营亏损：$(583,581)，反映出与去年相比，形成和运营成本的增加。</li>
<li>净亏损：$(1,119,910)，主要由于金融工具公允价值的变化和运营费用的增加。</li>
<li>每股基本和稀释净亏损，可能赎回的普通股：$(0.19)，表明每股亏损较去年有所增加。</li>
<li>每股基本和稀释净亏损，普通股：$(0.19)，与可能赎回的普通股每股亏损一致。</li>
</ul>
业务亮点
<ul>
<li>业务合并进展：NorthView Acquisition Corporation 正在与加利福尼亚公司 Profusa, Inc.完成业务合并。此次合并将导致 Profusa 成为 NorthView 的全资子公司，NorthView 将更名为 Profusa, Inc.</li>
<li>业务合并期限延长：公司已将完成业务合并的期限延长至 2025 年 6 月 22 日，经过股东批准。这一延长为 NorthView 提供了额外的时间来最终确定与 Profusa 的合并。</li>
<li>股东赎回：在报告期间，股东赎回了大量股份，影响了公司的信托账户余额。公司已采取措施管理这些赎回，包括与投资者签订非赎回协议。</li>
<li>可转换本票：NorthView 与其赞助商签订了一份可转换本票，该本票已修订以增加可提取的本金金额。该本票对融资与业务合并相关的交易成本至关重要。</li>
<li>证券购买协议：公司与一位机构投资者签订了证券购买协议，以购买高级担保可转换本票，这将为业务合并提供额外资金。</li>
<li>纳斯达克退市及场外市场报价：由于未在规定时间内完成业务合并，NorthView 的证券已从纳斯达克退市。公司的证券现在在场外市场报价。</li>
<li>未来展望：公司专注于在延长的截止日期之前完成与 Profusa 的业务合并。管理层正在积极努力满足合并所需的条件并获得必要的批准。</li>
</ul>
SEC 文件：NorthView Acquisition Corp [ NVAC ] - 10-Q -2025 年 6 月 13 日

NVAC

PFSA

NorthView Acquisition Corp 发布了其第三季度 10-Q 报告，显示净亏损为 1,119,910 美元，运营亏损为 583,581 美元。该公司正在与 Profusa, Inc. 合并，并将业务合并的截止日期延长至 2025 年 6 月 22 日。股东赎回对信托账户产生了影响，NorthView 已修订了一项可转换票据以进行融资。其证券在被纳斯达克退市后，目前在 OTC 市场报价。该公司旨在在新的截止日期之前完成与 Profusa 的合并

NorthView Acquisition Corp, a special purpose acquisition company (SPAC), has released its Form 10-Q report for the third quarter, detailing significant financial and operational developments. The company, which is in the process of merging with Profusa, Inc., a California-based biotechnology firm, has provided insights into its financial performance and strategic business activities during the reporting period.
<div class="lb-trans">NorthView Acquisition Corp，一家特殊目的收购公司（SPAC），已发布其第三季度的 10-Q 报告，详细说明了重要的财务和运营发展。该公司正在与位于加利福尼亚的生物技术公司 Profusa, Inc.合并，并提供了报告期间的财务表现和战略业务活动的见解。
</div>Financial Highlights
<div class="lb-trans">财务亮点
</div><ul>
<li>Loss from operations: $(583,581), reflecting an increase in formation and operating costs compared to the previous year.</li>
<li>Net Loss: $(1,119,910), primarily driven by changes in fair value of financial instruments and increased operating expenses.</li>
<li>Basic and diluted net loss per share, common stock subject to possible redemption: $(0.19), indicating a higher loss per share compared to the previous year.</li>
<li>Basic and diluted net loss per share, common stock: $(0.19), consistent with the loss per share for common stock subject to possible redemption.</li>
</ul>
<div class="lb-trans"><ul>
<li>运营亏损：$(583,581)，反映出与去年相比，形成和运营成本的增加。</li>
<li>净亏损：$(1,119,910)，主要由于金融工具公允价值的变化和运营费用的增加。</li>
<li>每股基本和稀释净亏损，可能赎回的普通股：$(0.19)，表明每股亏损较去年有所增加。</li>
<li>每股基本和稀释净亏损，普通股：$(0.19)，与可能赎回的普通股每股亏损一致。</li>
</ul>
</div>Business Highlights
<div class="lb-trans">业务亮点
</div><ul>
<li>Business Combination Progress: NorthView Acquisition Corporation is in the process of consummating a business combination with Profusa, Inc., a California corporation. This merger will result in Profusa becoming a wholly-owned subsidiary of NorthView, and NorthView will change its name to Profusa, Inc.</li>
<li>Extension of Business Combination Period: The company has extended the period to complete its business combination until June 22, 2025, following stockholder approval. This extension allows NorthView additional time to finalize the merger with Profusa.</li>
<li>Stockholder Redemptions: During the reporting period, stockholders redeemed a significant number of shares, impacting the company's trust account balance. The company has taken steps to manage these redemptions, including entering into a non-redemption agreement with investors.</li>
<li>Convertible Promissory Note: NorthView has a convertible promissory note with its sponsor, which has been amended to increase the principal amount available for drawdown. This note is crucial for financing transaction costs related to the business combination.</li>
<li>Securities Purchase Agreement: The company entered into a securities purchase agreement with an institutional investor for the purchase of senior secured convertible promissory notes, which will provide additional funding for the business combination.</li>
<li>Nasdaq Delisting and OTC Market Quotation: NorthView's securities were delisted from Nasdaq due to not completing a business combination within the required timeframe. The company's securities are now quoted on the OTC Market.</li>
<li>Future Outlook: The company is focused on completing the business combination with Profusa by the extended deadline. The management is actively working on meeting the conditions necessary for the merger and securing the required approvals.</li>
</ul>
<div class="lb-trans"><ul>
<li>业务合并进展：NorthView Acquisition Corporation 正在与加利福尼亚公司 Profusa, Inc.完成业务合并。此次合并将导致 Profusa 成为 NorthView 的全资子公司，NorthView 将更名为 Profusa, Inc.</li>
<li>业务合并期限延长：公司已将完成业务合并的期限延长至 2025 年 6 月 22 日，经过股东批准。这一延长为 NorthView 提供了额外的时间来最终确定与 Profusa 的合并。</li>
<li>股东赎回：在报告期间，股东赎回了大量股份，影响了公司的信托账户余额。公司已采取措施管理这些赎回，包括与投资者签订非赎回协议。</li>
<li>可转换本票：NorthView 与其赞助商签订了一份可转换本票，该本票已修订以增加可提取的本金金额。该本票对融资与业务合并相关的交易成本至关重要。</li>
<li>证券购买协议：公司与一位机构投资者签订了证券购买协议，以购买高级担保可转换本票，这将为业务合并提供额外资金。</li>
<li>纳斯达克退市及场外市场报价：由于未在规定时间内完成业务合并，NorthView 的证券已从纳斯达克退市。公司的证券现在在场外市场报价。</li>
<li>未来展望：公司专注于在延长的截止日期之前完成与 Profusa 的业务合并。管理层正在积极努力满足合并所需的条件并获得必要的批准。</li>
</ul>
</div>SEC Filing: NorthView Acquisition Corp [ NVAC ] - 10-Q - Jun. 13, 2025
<div class="lb-trans">SEC 文件：NorthView Acquisition Corp [ NVAC ] - 10-Q -2025 年 6 月 13 日
</div>

NorthView Acquisition Corp 的 SEC 10-Q 季度报告